https://media.ideayabio.com/ https://media.ideayabio.com/2026-09-28-IDEAYA-Biosciences-Announces-the-Promotion-of-Dr-Michael-White-to-President,-Research-and-Development Mon, 28 Sep 2026 06:00:00 -0400 https://media.ideayabio.com/2026-09-28-IDEAYA-Biosciences-Announces-the-Promotion-of-Dr-Michael-White-to-President,-Research-and-Development https://media.ideayabio.com/2026-09-25-IDEAYA-Biosciences-Announces-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4 Fri, 25 Sep 2026 06:00:00 -0400 https://media.ideayabio.com/2026-09-25-IDEAYA-Biosciences-Announces-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4 https://media.ideayabio.com/2026-09-09-IDEAYA-Biosciences-and-Servier-Announce-First-Patient-Dosed-in-OptimUM-11-Global-Phase-3-Registrational-Trial-of-Darovasertib-and-Crizotinib-as-Adjuvant-Therapy-for-Subjects-with-Uveal-Melanoma Wed, 09 Sep 2026 06:00:00 -0400 https://media.ideayabio.com/2026-09-09-IDEAYA-Biosciences-and-Servier-Announce-First-Patient-Dosed-in-OptimUM-11-Global-Phase-3-Registrational-Trial-of-Darovasertib-and-Crizotinib-as-Adjuvant-Therapy-for-Subjects-with-Uveal-Melanoma https://media.ideayabio.com/2026-09-01-IDEAYA-Biosciences-Announces-London-Investor-R-D-Day-and-Participation-in-Upcoming-September-2026-Investor-Conferences Tue, 01 Sep 2026 06:00:00 -0400 https://media.ideayabio.com/2026-09-01-IDEAYA-Biosciences-Announces-London-Investor-R-D-Day-and-Participation-in-Upcoming-September-2026-Investor-Conferences https://media.ideayabio.com/2026-08-31-IDEAYA-Biosciences-Announces-Successful-FDA-Type-C-Meeting-for-IDE849,-DLL3-TOP1-ADC,-on-Phase-3-Registrational-Trial-Design-for-Potential-Accelerated-and-Full-Approval-in-Extensive-Stage-Small-Cell-Lung-Cancer Mon, 31 Aug 2026 06:00:00 -0400 https://media.ideayabio.com/2026-08-31-IDEAYA-Biosciences-Announces-Successful-FDA-Type-C-Meeting-for-IDE849,-DLL3-TOP1-ADC,-on-Phase-3-Registrational-Trial-Design-for-Potential-Accelerated-and-Full-Approval-in-Extensive-Stage-Small-Cell-Lung-Cancer